WEST PHARMACEUTICAL SERVICES, INC. Payments to Acquire Businesses, Gross
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Payments to Acquire Businesses, Gross of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2024-02-20
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for the quarter ending 2020-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for the quarter ending 2020-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for the quarter ending 2019-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for the quarter ending 2019-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for fiscal 2023 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for fiscal 2021 was $2.20M.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire businesses, gross for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-20 | |||
| 2021-12-31 | $2.20M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $0.00 10-Q · filed 2020-10-23 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $18.90M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $18.90M 10-Q · filed 2020-10-23 | ||
| 2019-06-30 | $18.90M 10-Q · filed 2020-07-24 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $0.00 10-Q · filed 2019-10-29 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-29 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |